Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharmacyclics and Johnson & Johnson submit blood cancer drug ibrutinib to FDA for approval
Yahoo/AP
Wednesday, July 10, 2013 - 11:05am
tags:
JNJ, Pharmacyclics, ibrutinib, chronic lymphocytic leukemia
Employer Mandate: A Pharma Bump In The Road
Seeking Alpha
Wednesday, July 10, 2013 - 11:04am
tags:
Amgen, Merck, Pfizer, Affordable Care Act
Death Of A Drug Class Shows Difficulty Of Using Gene Data To Design Drugs
Forbes
Wednesday, July 10, 2013 - 10:32am
tags:
Aleglitazar, diabetes, Roche, PPAR
Theravance, GlaxoSmithKline: Breo Ellipta approved for COPD treatment in Canada
Yahoo/Fly on the Wall
Wednesday, July 10, 2013 - 10:26am
tags:
GSK, Breo Ellipta, Canada, Theravance, COPD
Merck's $5.7 Billion Diabetes Franchise Is Vulnerable
Seeking Alpha
Wednesday, July 10, 2013 - 10:25am
tags:
Merck, diabetes, Novo Nordisk, Eli Lilly, Novartis, Januvia
European regulators expand Pfizer vaccine age range to include adults ages 18 to 49 years
Yahoo/AP
Wednesday, July 10, 2013 - 9:11am
tags:
vaccines, Europe, Pfizer, Prevenar 13
What Liability? Merck Wins A Key Ruling That Bolsters Pharma Comment Now Follow Comments
Forbes
Wednesday, July 10, 2013 - 9:11am
tags:
Merck, Fosamax, Wyeth
Is The DMD Market Becoming Too Crowded?
Motley Fool
Tuesday, July 9, 2013 - 5:14pm
tags:
Duchenne Muscular Dystrophy, Sarepta, eteplirsen, drisapersen, GSK, PTC Therapeutics
Vivus signs impotence drug deal as proxy vote looms
Reuters
Tuesday, July 9, 2013 - 5:11pm
tags:
Vivus, erectile dysfunction, Avanafil, Menarini
A View Through An Open Window For Biotech IPOs
Forbes
Tuesday, July 9, 2013 - 12:29pm
tags:
biotech, IPOs
PharmAthene Vs. Siga: An Open Letter To Delaware's Vice Chancellor Parsons
Seeking Alpha
Tuesday, July 9, 2013 - 12:28pm
tags:
SIGA technologies, Delaware, PharmAthene, Arestvyr, ST-246
Pfizer's Projected $3B Drug: Name Will Shock You
Forbes
Tuesday, July 9, 2013 - 12:26pm
tags:
Pfizer, Lipitor
Why Peregrine Earnings Are Stuck in the Red
Motley Fool
Tuesday, July 9, 2013 - 11:45am
tags:
Peregrine Pharmaceuticals, earnings
GSK taps UK firm for "beyond antibodies" drug technology
Reuters
Tuesday, July 9, 2013 - 10:09am
tags:
GSK, Immunocore
CytRx’s Aldoxorubicin Shrinks Tumors and Prolongs Survival in Model of Human Brain Cancer
Yahoo
Tuesday, July 9, 2013 - 9:59am
tags:
CytRx, brain cancer, aldoxorubicin
Vivus says activist investor criticisms are off base
Yahoo/Reuters
Tuesday, July 9, 2013 - 9:57am
tags:
Vivus, investors, Qsymia
Grim Near-Term Prospects For Zogenix
Seeking Alpha
Tuesday, July 9, 2013 - 9:14am
tags:
Zogenix, Zohydro ER, chronic pain
Celgene Expanding R&D Portfolio Into Regenerative Medicine
Seeking Alpha
Tuesday, July 9, 2013 - 8:05am
tags:
R&D, regenerative medicine, Celgene, Tengion
Who Is the Best Suitor for Onyx?
Motley Fool
Tuesday, July 9, 2013 - 8:03am
tags:
M&A, ONYX Pharmaceuticals, Bayer, Amgen
Why Sunesis Is Poised to Pull Back
Motley Fool
Tuesday, July 9, 2013 - 8:02am
tags:
Sunesis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.